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Ultrasound-guided fine-needle aspiration cytology (FNAC) for suspicious cervical lymph nodes 
(CLN) is the gold standard technique for the identification of metastases from differentiated 
thyroid carcinomas. Thyroglobulin protein (Tgp) assay in the washout of needles employed for 
FNA biopsies (FNAB) has been reported to refine and support FNAC performances, especially 
in cases of inadequate sampling or cystic lymph nodes. In the present work, we evaluated the 
usefulness of routine measurement of Tgp in the FNAB washout of suspicious cervical lymph 
nodes (CLN), and its ability to increase the FNAC accuracy in the diagnosis of metastatic CLN.
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Introduction
FNAC - Ultrasound-Guided Fine-Needle Aspiration Cytology
Tgp - Thyroglobulin Protein
FNAB - Fine-Needle Aspiration Biopsies
CLN - Cervical Lymph Nodes
PTC - Papillary Thyroid Carcinomas
MTC - Medullary Thyroid Cancer
ATC - Anaplastic Thyroid Cancer
DTC - Differentiated Thyroid Carcinomas
PDTC - Poorly Differentiated Thyroid Carcinomas
Thyroid cancer (TC) is the most common type of endocrine neoplasia, accounting for 3.1% of all new cancers 
and for 0.4% of cancer-related deaths worldwide in 2018 [1,2]. The majority of TC arise from the epithelial 
follicular cells, and are classified as differentiated thyroid carcinomas (DTC), comprising the papillary 
(PTC) and follicular (FTC) carcinomas, poorly differentiated (PDTC) and anaplastic thyroid carcinomas 
(ATC) [3]. Medullary thyroid carcinomas (MTC), originated from the parafollicular C cells, represent 
5-10% of thyroid cancers with a 1-2% prevalence in thyroid nodules [3]. The annual incidence of TC has 
displayed an increasing trend in the last decades which, however, is not attributable to a real escalation in 
the onset of tumors, but rather to the improved detection of microcarcinomas in small non-palpable thyroid 
nodules [4]. The latter are very common, with a prevalence of 19% to 67% in the adult population, while 
malignant lesions occur only in about 5% of them [5,6]. Therefore, the first aim of clinical evaluation of 
thyroid nodules is to discriminate against their benign or malignant nature [5,6]. In this regard, fine-needle 
aspiration cytology (FNAC) represents the main diagnostic tool owing to its good diagnostic accuracy 
(84-95%), reproducibility and cost effectiveness [5-9]. Total thyroidectomy, with eventual dissection of the 
central and/or lateral compartment neck, is recommended for TC patients, followed in most cases by I131 
ablation of the remnant [5,6,10,11].
A case study of 45 CLN with histological diagnosis from 36 patients was analyzed. Histology 
showed metastases from papillary thyroid carcinomas (PTC) in 31 CLN, from anaplastic thyroid 
cancer (ATC) in 3 CLN, from medullary thyroid cancer (MTC) in 4 CLN, and metastases from 
extrathyroidal malignancies in 5 CLN. Two CLN analyzed were found to be non-neoplastic.
The overall accuracy of FNAC was 82.9%, and that of Tgp was 91.1%, not statistically different. 
However, Tgp determination was found essential in 4 cases of metastatic CLN from DTC with 
inadequate cytology, and in 1 case in which the FNAC provided a false negative result.
We demonstrated that FNAC and Tgp assay show similar diagnostic accuracies, and that Tgp 
measurement may represent the only available information in case of inadequate lymph node 
sampling or cystic lymph nodes.
Enke Baldini, et al. (2019). Thyroglobulin Measurement in the Washout of Fine Needle Aspirates for the 
Diagnosis of Suspicious Cervical Lymph Nodes. CPQ Cancer, 1(5), 01-12.
Enke Baldini, et al., CPQ Cancer (2019) 1:5 Page 3 of 12
From September 2004 to June 2016, FNAC and Tgp measurements were performed in parallel on suspicious 
CLN at the outpatients’ clinic of Endocrinology and Thyroid Diseases of the Polyclinic Umberto I of Rome 
(Italy). Forty-five CLN obtained from 36 consecutive patients, for which histological report was available, 
were selected for the present study. Of these 32 CLN, corresponding to 26 patients, were already analyzed 
in a previous report [44]. The present study received the approval of the ethical committee of the Polyclinic 
Umberto I (protocol no. 2615), and all patients signed the consent form. Twelve males and 24 females 
(median age 44 yr, range 20-76 yr) were subjected to FNAB in one or multiple suspicious CLN. Among 
them, 10 patients had been formerly thyroidectomized for PTC, and hence they were suspected of relapse 
(see table 1). All patients with preoperative diagnosis of TC underwent unilateral neck dissection. The 
histological analysis evidenced that, of the 45 CLN analyzed, 31 had metastatic PTC, 4 had metastatic 
MTC, 3 had metastatic ATC, and 5 harbored metastases from extrathyroidal cancers (metastasis from non-
Hodgkin lymphoma were contained in 3 CLN, metastasis from a rhino-pharyngeal carcinoma in 1 CLN, 
and metastasis from lung carcinoma in 1 CLN). Cervical lymph nodes 41 and 45 (patients 32 and 36) of 
table 1, with a non-neoplastic cytological diagnosis underwent surgical removal because of the presence of 
thyroid nodule with cytological diagnosis of PTC, that following surgery was confirmed by histology.
Here, we evaluated 45 CLN with histological report to assess the diagnostic value of Tgp, quantified in the 
washout of needles used for FNAC, in the identification of lymph nodal metastasis from thyroid tumors. 
The results showed that FNAC and Tgp have a similar diagnostic performance, and that Tgp could be 
informative in case of inadequate lymph node sampling.
Materials and Methods
Patients
Post-operative management of patients comprises periodic neck ultrasound, I131 whole-body scintigraphy, 
and serum Tg measurement after exogenous stimulation with recombinant human TSH 6-12 months 
after surgery [5,6]. DTC patients have a favorable prognosis, with 10-years-survival rate of roughly 90%. 
Nonetheless, approximately 10% to 15% of them exhibit persistent or recurrent TC, one third of whom face 
the loss of radioiodine avidity, poor response to conventional therapies and cancer-related death [5,6,10]. 
For such reasons, the identification of new prognostic molecular markers is highly required to improve the 
prognostic stratification of thyroid cancer patients [12-18].
Most of relapses appear within the central or lateral neck. When a mass in the thyroid bed and/or a 
lymphadenopathy are observed by ultrasound, FNAB is performed to diagnose a locally recurrent TC. 
Therefore, at present, FNAC is of crucial importance both in preoperative phase, to establish the surgical 
approach and prognostic stratification of TC patients, and in the follow-up to identify relapses [5,6,10,19-
22]. An important limitation of this technique is that it depends totally on pathologist’s experience for 
recognition of metastases from TC, metastases from extra-thyroidal neoplasms or non-tumoral diseases 
[23-25]. In addition, it is worth to note that inadequate cellularity prevents diagnosis in approximately 15% 
of cases [26-28]. Several studies suggested that measurement of thyroglobulin protein (Tgp) in the washout 
of the same needle used for FNAC could improve the diagnostic accuracy on CLN harboring metastases 
from DTC [29-46]. As a consequence, routine association of Tgp with FNAC in the diagnosis of CLN 
metastasis from DTC has been endorsed [29-46].
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Table 1: Patient’s age and gender, cytological, molecular and histological diagnoses of suspicious metastatic cervical lymph nodes (CLN) included in the 










1 Inadequate 6620 PTC
2 Inadequate 7480 PTC
2 28 F 3 PTC 5652 PTC
3* 69 F 4 PTC 5293 PTC
4* 54 F 5 PTC 18612 PTC
5 46 F 6 PTC 1625 PTC
6 45 M 7 MTC 0.9 MTC
7* 28 F 8 Inadequate 37.5 PTC
8 35 M 9 PTC 26108 PTC
9 66 F 10 ATC <0.15 ATC
10 52 F 11 PTC 37250 PTC
11 69 M
12 PTC 0.8 ATC
13 PTC 2.82 ATC
12* 63 F 14 PTC 114 PTC
13* 34 F 15 PTC 288 PTC
14 30 F
16 PTC 1151 PTC
17 PTC 3714 PTC
15 34 F 18 PTC 480 PTC
16 29 M
19 PTC <0.15 MTC
20 PTC <0.15 MTC
17* 33 F 21 PTC 62908 PTC
18 31 F
22 PTC 72.3 PTC
23 PTC 10349 PTC
19 25 M 24 PTC 384 PTC
20* 53 F 25 PTC 728 PTC
21 68 M 26 PTC 53 PTC
22 41 M 27 Epithelial cancer <0.15 RPC
23 71 F 28 Lymphoma 10.9 Lymphoma
24 68 F 29 Lung cancer <0.15 Lung cancer
25 38 M 30 PTC 3361 PTC
26* 28 F
31 Non-neoplastic 4395 PTC
32 PTC 4388 PTC
27 43 F 33 PTC 125 PTC
28 58 F
34 PTC 1580 PTC
35 PTC 562 PTC
29* 25 F 36 Inadequate <0.15 PTC
30 56 F
37 Non-neoplastic <0.15 Lymphoma
38 Non-neoplastic <0.15 Lymphoma
31 62 F 39 PTC 87.7 PTC
32* 51 M
40 PTC 7810 PTC
41 Non-neoplastic <0.15 Non-neoplastic
33 21 M 42 PTC 27359 PTC
34 25 F 43 PTC 9632 PTC
35 76 M 44 MTC <0.15 MTC
36 62 M 45 Non-neoplastic <0.15 Non-neoplastic
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Each CLN was stung for aspiration two or three times with a 22-gauge needle, performing a minimum of 2 
and a maximum of 4 passes every time for adequate sampling. The aspirates were expelled onto one or more 
glass slides and prepared as previously described [44]. After that, the needle was rinsed in 1 ml of sterile 
phosphate buffered saline (PBS), which was centrifuged at 1200rpm for 5min. in order to eliminate cellular 
debris. Supernatants were then transferred in new tubes and frozen at -20ºC until Tgp assay.
Ultrasonography (US) was carried out by means of the Aplio XV (Toshiba, Japan) system equipped with a 
linear transducer (PLT-805AT). The following US parameters were considered suggestive of tumor spreading 
to CLN: rounded shape, long axis/short axis ratio < 1.5, irregular echotexture, absence of echogenic hilum, 
sharp borders, presence of microcalcifications, liquefaction or coagulation necrosis, aberrant distribution 
of vessels. Patients selected for FNAB on the basis of US characters were recommended not to take 
anticoagulants during the 5 days before procedure.
Both slides and surgical samples were examined by three experienced pathologists (CDG, VA, ER and DB), 
which delivered consistent reports in all cases. All pathologists were unaware of Tgp results and, vice versa, 
the biologists who carried out the Tgp assay were uninformed of the pathologists’ diagnoses.
Ultrasonography and Fine-Needle Aspiration Biopsy (FNAB)
Cytological and Histological Analysis
All the FNAB washouts were analyzed within 10 days from collection. Tgp and Tg autoantibody assays 
were accomplished with, respectively, the immune-luminometric assay Tg-PluS and the Anti-Tgn kit from 
Tgp and Tg Autoantibody Measurements
As reported in table 1, FNAC turned out to be inadequate in 4 (8.9%) out of the 45 CLN samples analyzed. 
The FNAC diagnosis was correctly provided in 34 cases out of 41 CLN, with an overall accuracy of 82.9%. 
In the remaining 7 cases, cytology erroneously identified 4 metastatic PTC that histology reported as 2 
metastatic MTC (table 1, CLN n. 19 and 20) and 2 metastatic ATC (table 1, CLN n. 12 and 13); of 3 
cytological diagnoses of non-neoplastic CLN, 1 was found to be a metastatic PTC (table 1, CLN n. 31), and
Results
B.R.A.H.M.S. (Hennigsdorf, Germany). All samples were read in duplicate, and in some cases read back 
after dilution in PBS. Results were expressed as ng/FNAB, and Tgp values below 0.15ng/ml, i.e. the 
functional sensitivity of assay, were considered negative. All samples were negative for the presence of Tg 
autoantibodies.
Performances of FNAC and Tgp tests were compared by the one-tail Fisher exact test and refereed as 
statistically significant when the pertaining p value was < 0.05. Statistical analyses were made using the Stata 
software, version 8.0 (College Station, Texas, Stata Corporation, 2003).
Statistical Analysis
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Table 2: Diagnostic performances of fine-needle aspiration cytology (FNAC) and thyroglobulin protein (Tgp) 
assay for the diagnosis of all suspicious metastatic cervical lymph nodes (CLN) (n=45). PPV, positive predictive 
value; NPV, negative predictive value. In round brackets the number of cases. In square brackets the 95% 
confidence interval.
the other 2 were found to be lymphomas at histology (table 1, CLN n. 37 and 38). These 7 FNAC diagnoses 
were considered as false negative.
In agreement with other studies, we decided to adopt a Tgp cut-off of 1ng/FNAB, as it offered a good 
discrimination of tumors limiting false negative results at the same time [44, 46-48]. In these conditions, 
Tgp provided correct diagnoses in 41 CLN (31 true positive and 10 true negative), false negative results 
in 3 CLN, comprising 2 metastatic ATC (table 1, CLN n. 9 and 11), and one false positive in a CLN 
affected by lymphoma (table 1, CLN n. 28). Specificity, sensitivity, positive (PPV) and negative (NPV) 
predictive values, and accuracy are reported for FNAC and Tgp in table 2. It may be appreciated as Tgp 
showed a statistically significant higher NPV, while no differences were recorded among the two diagnostic 
approaches for sensitivity, specificity, PPV and overall accuracy. The comparison between these parameters of 
FNAC and Tgp was performed by analyzing either PTC and ATC taken together or the PTC cases alone 
(see table 3). In both situations, no statistically significant differences were observed among the different 
diagnostic results.
FNAC Tgp p
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Table 3: Diagnostic performances of fine-needle aspiration cytology (FNAC) and thyroglobulin protein (Tgp) 
assay for the diagnosis of suspicious metastatic cervical lymph nodes (CLN) of epithelial thyroid cancer patients 
(PTC+ATC) (n=36) or only PTC (n=33). PPV, positive predictive value; NPV, negative predictive value. In 
round brackets the number of cases. In square brackets the 95% confidence interval.
FNAC Tgp p
PTC + ATC































In the present study, we showed that US-guided FNAC and Tgp assay had the same overall accuracy in the 
diagnosis of cervical lymph nodes (CLN) suspicious of malignancy. Although dependent on the experience 
and ability of the cytopathologists, FNAC was widely documented to be a reliable method for identifying 
CLN metastases, not only derived from thyroid cancers but also from other primary malignancies, as well 
as in recognizing non-tumoral diseases affecting CLN. Since the first observation, reported by Pacini and 
colleagues in 1992 (32), that Tgp determination in fine-needle washout could improve the accuracy of 
FNAC in the diagnosis of DTC metastatic CLN, several studies have confirmed its clinical utility, and its 
routine association with FNAC in the preoperative diagnosis of suspicious CLN has been recommended 
[11, 29-47]. 
Discussions
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FNAC represents the standard modality of evaluation of lymph-nodal metastases originated either from 
thyroid cancers or from other primary tumors. In the specific case of DTC detection, it is possible to 
combine this technique with Tg protein measurement without the need for further sampling. The results 
of the present study confirm previous observations about the diagnostic utility of Tgp assay in the FNA 
washout of CLN suspicious of metastatic thyroid cancer, particularly in the case of inadequate lymph node 
sampling.
Conclusions
Our experience on 45 CLN with available histological report encompassed cases of CLN harboring 
metastases from PTC, MTC, ATC, and non-thyroidal primary tumors. Considering the 36 CLN with 
metastases from PTC and ATC as a unique group, FNAC exhibited 90.6% accuracy, a datum in line with 
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genes typically occurring in this cancer. In fact, in one of these lymph nodes the Tgp was still detectable 
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